论文信息 - Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301 - 字舞流文

Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301

M. Tomonaga | A. Utsunomiya | K. Itoh | T. Chou | T. Hotta | S. Matsuda | M. Hirano | F. Mizorogi | M. Shimoyama | Takayo Suzuki | K. Deura | S. Konda | M. Sano | C. Mikuni | T. Sai | T. Takenaka | Lymphoma Study Group of the Japan Clinical Oncology Group | H. Nagoshi | K. Tsushita | T. Ohno | Takashi Yamada | K. Kawano